TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 22 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,184,000 | -26.5% | 241,536 | 0.0% | 0.78% | +42.6% |
| Q3 2016 | $1,611,000 | +52.3% | 241,536 | 0.0% | 0.55% | +29.8% |
| Q2 2016 | $1,058,000 | -37.3% | 241,536 | 0.0% | 0.42% | -39.7% |
| Q1 2016 | $1,688,000 | -24.4% | 241,536 | 0.0% | 0.70% | +11.6% |
| Q4 2015 | $2,232,000 | -8.6% | 241,536 | -3.4% | 0.63% | +34.5% |
| Q3 2015 | $2,442,000 | -13.8% | 250,000 | 0.0% | 0.47% | +74.9% |
| Q2 2015 | $2,832,000 | -19.3% | 250,000 | 0.0% | 0.27% | -19.3% |
| Q1 2015 | $3,510,000 | – | 250,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 995,000 | $3,134,000 | 0.33% |
| NEA Management Company, LLC | 2,759,217 | $8,692,000 | 0.30% |
| Eventide Asset Management | 900,000 | $2,835,000 | 0.16% |
| QVT Financial LP | 308,227 | $916,000 | 0.03% |
| Candriam S.C.A. | 143,000 | $450,000 | 0.01% |
| Virtu Financial LLC | 23,684 | $75,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,352 | $42,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 16,000 | $50,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,135 | $171,000 | 0.00% |
| Alyeska Investment Group, L.P. | 97,676 | $308,000 | 0.00% |